Nanobody Shows Promise in Myasthenia Gravis

Summary
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly...
Description from Medpagetoday.
Who is covering this
-
Nanobody Shows Promise in Myasthenia Gravis
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly...
Comments
Comments need JavaScript.